Stryker (SYK) Net Cash Flow Growth (3y) (2012 - 2026)
Stryker (SYK) Net Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | -9.45% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 60.16% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | -85.83% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 43.26% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | -26.30% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 21.48% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -127.77% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 269.22% |
| 10 | Zimmer Biomet Holdings | 19.18 Bn | 18.77 Bn | 1.54 Bn | -45.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 60.16% |
| Mar 31, 2026 | -87.87% |
| Dec 31, 2025 | 23.55% |
| Sep 30, 2025 | 28.16% |
| Jun 30, 2025 | 26.99% |
| Mar 31, 2025 | 3.10% |
| Dec 31, 2024 | -34.20% |
| Sep 30, 2024 | 79.51% |
| Mar 31, 2024 | 3.72% |
| Dec 31, 2023 | 31.26% |
| Sep 30, 2023 | -2.30% |
| Jun 30, 2023 | -28.01% |
| Mar 31, 2023 | 20.94% |
| Dec 31, 2022 | -45.04% |
| Sep 30, 2022 | 24.23% |
| Jun 30, 2022 | -89.08% |
| Mar 31, 2022 | 8.46% |
| Dec 31, 2021 | -38.34% |
| Sep 30, 2021 | 6.10% |
| Mar 31, 2021 | -19.64% |